P300 Amplitude in Alzheimer's Disease

99Citations
Citations of this article
88Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Alzheimer's disease accounts for 60% of all dementia. Numerous biomarkers have been developed that can help in making an early diagnosis. The P300 is an event-related potential that may be abnormal in Alzheimer's disease. Given the possible association between P300 amplitude and Alzheimer's disease and the need for biomarkers in early Alzheimer's disease, the main purpose of this meta-analysis and meta-regression was to characterize P300 amplitude in probable Alzheimer's disease compared to healthy controls. Using online search engines, we identified peer-reviewed articles containing amplitude measures for the P300 in response to a visual or auditory oddball stimulus in subjects with Alzheimer's disease and in a healthy control group and pooled effect sizes for differences in P300 amplitude between Alzheimer's disease and control groups to obtain summary effect sizes. We also used meta-regression to determine whether age, sex, educational attainment, or dementia severity affected the association between P300 amplitude and Alzheimer's disease. Twenty articles containing a total of 646 subjects met inclusion and exclusion criteria. The overall effect size from all electrode locations was 1.079 (95% confidence interval = 0.745-1.412, P

Cite

CITATION STYLE

APA

Hedges, D., Janis, R., Mickelson, S., Keith, C., Bennett, D. A. V. I. D., & Brown, B. L. (2016). P300 Amplitude in Alzheimer’s Disease. Clinical EEG and Neuroscience, 47(1), 48–55. https://doi.org/10.1177/1550059414550567

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free